Axis Clinicals Limited. Trident Chemphar Ltd. RPR Sons Advisors Pvt. Ltd. jointly holding's Insider Trades & SAST Disclosures
No reported Insider Trades available for Axis Clinicals Limited. Trident Chemphar Ltd. RPR Sons Advisors Pvt. Ltd. jointly holding in the Trendlyne database.
Axis Clinicals Limited. Trident Chemphar Ltd. RPR Sons Advisors Pvt. Ltd. jointly holding's has made SAST transactions in Aurobindo Pharma Ltd. recently where a Pledge of 3,400,000 shares done . Disclosure was reported to the exchange on Feb. 17, 2021.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | Axis Clinicals Limited (jointly holding with Trident Chemphar Limited and RPR Sons Advisors Pvt.Ltd) | Promoter | Pledge | 24 Dec 2024 | 3,400,000 | 3,410,000 | - | - | 17 Feb 2021 17 Feb 2021 |
SAST (Reg31) | - | Creation |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.